Fosun Reports 160% Profit Surge, Highlights Core Business…

Event summary

Fosun International reported a 160.3% year-on-year increase in profit attributable to owners of the parent, reaching RMB1.72 billion for the first half of 2026.
Total revenue for the period was RMB86.96 billion, with overseas revenue accounting for 56.5% of the total.
Four core companies—Fosun Pharma, Yuyuan, Fosun Insurance Portugal (Fidelidade), and the Tourism segment—generated 73.5% of the Group's total revenue.
Fosun invested RMB4.2 billion in technology innovation in the first half of 2026, a 16.7% year-on-year increase.
The company aims to achieve investment-grade credit rating status and focus on industries where it holds competitive advantages.

The big picture

Fosun's strong interim results reflect its strategic focus on core businesses and global expansion. The company's emphasis on innovation and integration aligns with broader industry trends toward digital transformation and cross-sector synergies. With a commitment to achieving investment-grade status, Fosun is positioning itself for sustained growth in competitive markets.

What we're watching

Integration Strategy: How Fosun's integration of its insurance business with core industries will impact long-term profitability and operational capabilities.
Global Expansion: Whether Fosun can sustain its overseas revenue growth and strengthen its global commercialization capabilities.
Innovation Investments: The pace at which Fosun's substantial investments in technology innovation will translate into market-leading products and services.